学者主页 | 科言猫

University of Siena

H指数:0

被引数:2,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional, electrophysiology, and molecular dynamics analysis of quercetin-induced contraction of rat vascular musculature

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2022-03-0121

PRE

Flavonoids and hERG channels: Friends or foes?

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-05-019

PREAI

Fine tuning by protein kinases of CaV1.2 channel current in rat tail artery myocytes

通过大鼠尾动脉肌细胞中CaV1.2通道电流的蛋白激酶进行微调

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-12-013

PREAI

Ritanserin blocks CaV1.2 channels in rat artery smooth muscles: electrophysiological, functional, and computational studies

ACTA PHARMACOLOGICA SINICA

IF8.4

2020-03-048

OAAI

The beneficial health effects of flavonoids on the cardiovascular system: Focus on K+ channels

类黄酮对心血管系统的有益健康作用: 关注K通道

PHARMACOLOGICAL RESEARCH

IF10.5

2020-02-0165

PREAI

Negative chronotropism, positive inotropism and lusitropism of 3,5-di-t-butyl-4-hydroxyanisole (DTBHA) on rat heart preparations occur through reduction of RyR2 Ca2+ leak

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-09-0113

PREAI

Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies

通过PKA抑制剂H-89的Cav1.2通道电流通过不依赖于PKA的机制在大鼠尾动脉肌细胞中阻断: 电生理，功能和分子对接研究

BIOCHEMICAL PHARMACOLOGY

IF5.6

2017-09-0119

PREAI

The surge of flavonoids as novel, fine regulators of cardiovascular Cav channels

类黄酮作为心血管Cav通道的新型精细调节剂的激增

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2017-02-0151

OAAI

Human Tuberculosis I. Epidemiology, Diagnosis and Pathogenetic Mechanisms

CURRENT MEDICINAL CHEMISTRY

IF3.5

2016-09-0527

Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy

人类结核病。三。抗结核治疗的当前和未来方法

CURRENT MEDICINAL CHEMISTRY

IF3.5

2016-08-113

PRE

Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs

CURRENT MEDICINAL CHEMISTRY

IF3.5

2016-05-026

PRE

Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses

BIOCHEMICAL PHARMACOLOGY

IF5.6

2016-03-0143

OAAI

The vasodilator papaverine stimulates L-type Ca2+ current in rat tail artery myocytes via a PKA-dependent mechanism

血管扩张剂罂粟碱通过PKA依赖性机制刺激大鼠尾动脉肌细胞中的L型Ca2电流

VASCULAR PHARMACOLOGY

IF3.5

2016-01-0128

PREAI

Reversion of Nitrate Tolerance in Rat Aorta Rings by Freeze-dried Red Wine

PHYTOTHERAPY RESEARCH

IF6.3

2015-01-104

PREAI

Vascular L-Type Ca2+ Channel Blocking Activity of Sulfur-Containing Indole Alkaloids from Glycosmis petelotii

JOURNAL OF NATURAL PRODUCTS

IF3.6

2014-06-2018

PREAI

2-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparations

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2013-08-017

PREAI

Quercetin relaxes rat tail main artery partly via a PKG-mediated stimulation of KCa1.1 channels

ACTA PHYSIOLOGICA

IF5.6

2013-03-2528

PREAI

A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury

PHARMACOLOGICAL RESEARCH

IF10.5

2012-12-0134

PRE

Effects of commonly used protein kinase inhibitors on vascular contraction and L-type Ca2+ current

常用蛋白激酶抑制剂对血管收缩和L型Ca2电流的影响

BIOCHEMICAL PHARMACOLOGY

IF5.6

2012-10-019

PREAI

Gold Nanoparticles Uptake and Cytotoxicity Assessed on Rat Liver Precision-Cut Slices

TOXICOLOGICAL SCIENCES

IF4.1

2012-07-0345

OAAI

个人简介

教育背景

工作经历

荣誉奖项

研究方向